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ABSTRACT
The use of secretion pathways for effector molecule delivery by microorganisms is a trademark of
pathogenesis. Leishmania extracellular vesicles (EVs) were shown to have significant immunomo-
dulatory potential. Still, they will act in conjunction with other released parasite-derived products
that might modify the EVs effects. Notwithstanding, the immunomodulatory properties of these
non-vesicular components and their influence in the infectious process remains unknown. To
address this, we explored both in vitro and in vivo the immunomodulatory potential of promas-
tigotes extracellular material (EXO), obtained as a whole or separated in two different fractions:
EVs or vesicle depleted EXO (VDE). Using an air pouch model, we observed that EVs and VDE
induced a dose-dependent cell recruitment profile different from the one obtained with parasites,
attracting significantly fewer neutrophils and more dendritic cells (DCs). Additionally, when we
co-inoculated parasites with extracellular products a drop in cell recruitment was observed.
Moreover, in vitro, while VDE (but not EVs) downregulated the expression of DCs and macro-
phages activation markers, both products were able to diminish the responsiveness of these cells
to LPS. Finally, the presence of Leishmania infantum extracellular products in the inoculum
promoted a dose-dependent infection potentiation in vivo, highlighting their relevance for the
infectious process. In conclusion, our data demonstrate that EVs are not the only relevant players
among the parasite exogenous products. This, together with the dose-dependency observed,
opens new avenues to the comprehension of Leishmania infectious process. The approach
presented here should be exploited to revisit existing data and considered for future studies in
other infection models.
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Microorganisms influence and are influenced by their
surroundings in a dynamic process, representing the
main driving force in evolution. The interactions between
the immune system and microbial pathogens take this to
the extreme in a millennia-old struggle for survival.
Protozoan parasites of the genus Leishmania are an excel-
lent example. Remarkably, amastigotes, the parasite intra-
cellular form, evolved to survive and proliferate in the
inhospitable environment of the macrophage phagolyso-
some [1]. This remarkable adaptation ultimately contri-
butes to Leishmania pathogenicity, being these protozoa
responsible for a spectrum of diseases designated as leish-
maniasis. Annually an estimated 1.3 million new cases
and 20 000 to 30 000 deaths are associated with these
diseases [2]. The absence of human vaccines to prevent
leishmaniasis [3] and the risks associated with conven-
tional therapies urge for a better understanding of the
infectious process.
The comprehension of the immune response asso-
ciated with Leishmania infection is a fast evolving field
comprising different parasite species and infection mod-
els [4]. It is accepted that infection success depends on the
parasite capacity to manipulate the immune system dur-
ing the first stages of the infection [5]. Leishmania pro-
mastigotes are transmitted during the blood-feeding
process of infected sand flies. In this context, components
of the initial inoculum such as the sand fly saliva and
parasite-derived products, like promastigote secretory gel
(PSG), have been evaluated for their possible roles in the
establishment of infection [6,7]. More recently also
Leishmania derived extracellular vesicles (EVs) have
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been recovered from sand fly midguts and were presented
as possible players during the initial steps of infection [8].
These EVs were found similar in composition to in vitro
recovered EVs validating the in vitro approaches as
a valuable source of biologically relevant EVs [8].
However, depending on the approach used to produce
the conditioned media (continuous vs. discontinuous)
from which the EVs are recovered, different proteomic
profiles are obtained [9]. Significantly, our group
reported previously that only in continuous culture con-
ditions the EVs from stationary parasites are dominated
by GP63 [9], whose immunomodulatory properties
enable direct modulation of host signalling [10–13].
This virulence factor has been a focus of several
Leishmania EVs studies [14,15]. Additionally, other
known immunomodulatory proteins like aldolase, elon-
gation factor 1-α and kinetoplastid membrane 11 were
also detected by us and others in EVs preparations
[9,16–18].
EVs are often treated as isolated entities and the
contribution of other secreted components is not
accounted for in the many studies published over the
years [19,20]. Leishmania promastigotes derived EVs
are no exception; they are part of the extracellular
products released by the parasite while residing inside
the sand fly. Therefore, it is important to understand if
reported Leishmania EVs immunological properties are
maintained in the context of other extracellular pro-
ducts. The Leishmania extracellular material (EXO) can
be separated physically into two distinct components:
EVs and vesicle depleted EXO (VDE) [9]. The relative
abundance and protein composition of the VDE and
EVs were previously characterized by us [9], and are
different, suggesting that they might have distinct
immunomodulatory potential. Herein we compare the
impact of distinct EXO amounts and its fractions, EVs
and VDE, in cell recruitment, antigen presenting cells
responsiveness (DCs and macrophages) and infection
outcome both in vitro and in vivo. Ultimately, the
characterized immunomodulatory properties of each
fraction translate into a dose-dependent potentiation
of infection, which can be translated to the natural
infection, considering the secretome as a whole.
Materials and methods
Ethics statement
All animal experiments were carried out in accordance
with the IBMC.INEB Animal Ethics Committees and
the Portuguese National Authorities for Animal Health
guidelines, according to the statements on the Directive
2010/63/EU of the European Parliament and of the
Council. BPC, NS and ACS have an accreditation for
animal research given by the Portuguese Veterinary
Direction (Ministerial Directive 1005/92).
Leishmania infantum culture
A cloned line of virulent Leishmania infantum
(MHOM/MA/67/ITMAP-263) freshly recovered from
BALB/c mice was used for a total of 10 passages.
Promastigotes were routinely maintained at 26°C in
standard RPMI 1640 medium supplemented with 10%
heat-inactivated Fetal Calf Serum (FCS; Biowest,
Nuaillé, France), 2 mM L-glutamine, 100 U/ml peni-
cillin, 100 μg/ml streptomycin and 20 mM HEPES
buffer, all products from Lonza (Basel, Switzerland).
For extracellular products obtention, parasites were
previously adapted and then sub-cultured (26°C) for
4 days (stationary phase [21]) in serum-free culture
media – cRPMI [RPMI base complemented with 10%
SDM-79 base and 2.5 μg/ml of hemin (Sigma-Aldrich,
St. Louis, MO, USA)] – that we previously developed
and validated for exoproteome studies [9,21]. All main-
tenance cultures were grown with a starting inoculum
of 106 parasites/ml.
Extracellular products recovery
Promastigotes were cultured at an initial concentration
of 2 × 106 parasites/ml in cRPMI. After 4 days the
parasites were removed by centrifugation at 1800 g
during 10 min at 4°C. The recovered conditioned
media (always on ice from this point on) was passed
through a 0.45 µm filter to remove any remaining
parasites and concentrated at 4000 g and 8°C using
100 kDa Amicon® Ultra Centrifuge Filters, Ultracol®
(Merck Millipore, Billerica, MA, USA) until the resi-
dual volume was less than 500 µl. The full volume of
the 100 kDa concentrate was dialyzed twice with 15 ml
of PBS until a residual volume of less than 500 µl. The
flow-through was stored for VDE recovery. For EXO
the process was similar, but using 3 kDa Amicon® Ultra
Centrifuge Filters, Ultracol®. The 100 kDa fraction con-
taining the EVs was then transferred to Ultra-ClearTM
centrifuge tubes for centrifugation in the Beckman
Coulter, optima L-80 XP ultracentrifuge with a SW41
rotor for 14 h at 100 000 g and 4°C. The following day
the supernatant was recovered without disturbing the
pellet, for VDE concentration. The pellet was sus-
pended and dialyzed twice with 15 ml of PBS using
the 100 kDa columns mentioned above until a final
volume of less than 500 µl was reached. For the VDE,
the process began by centrifuging the stored filtrate
from the 100 kDa filtrations, together with the
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supernatant from the ultracentrifugation through
3 kDa Amicon® Ultra Centrifuge Filters, Ultracol®, fol-
lowed by two consecutive dialyses with 15 ml PBS until
the residual volume was less than 500 µl. All the
volumes of the preparations were then adjusted to the
volume containing the material released by 107 para-
sites/µl that we represent in the manuscript as “e7”. In
the assays e6 (0.1 µl), e7 (1 µl), e8 (10 µl) and e9 (100 µl)
were used. For the biological assays, all stimuli were
used within the 24 h after purification. Proteomic stu-
dies of similarly obtained preparations were already
performed and analysed (EV TRACK ID:
EV180055) [9].
Transmission electron microscopy
The EXO, EVs and VDE were observed by
Transmission electron microscopy (TEM). For this,
equivalent amounts of the recovered preparations
were placed onto Formvar/Carbon-coated copper
grids and stained with an aqueous solution of 3%
uranyl acetate (Sigma-Aldrich, St. Louis, MO, USA)
for 10 min. Samples were viewed in a Zeiss model
EM 10C electron microscope.
Extracellular vesicles size determination
The average EVs size determination was performed using
TEM, dynamic light scattering (DLS) and Nanoparticle
Tracking Analysis (NTA). The particle diameter from
the TEM images was determined using the ImageJ soft-
ware package version 1.43u. A total number of 1000
particles from images from 5 different experiments were
used for the size estimation. Concerning the Z average
size and the polydispersity index determinations, they
were performed using a Zetasizer Nano ZS (Malvern
Instruments, Malvern, UK) with a detection angle of
173⁰. Measurements were made in triplicate at 25⁰C and
analysed with the Zetasizer series software – version 7.01.
For NTA the determinations were performed using
a NanoSight NS300 (Malvern Instruments, Malvern,
UK) with the software version NTA 3.0.
EV-TRACK
We have submitted all relevant data of our experiments
to the EV-TRACK knowledgebase (EV-TRACK ID:
EV180058) [22].
Mice
Female BALB/c mice were purchased from Charles
River Laboratories (France) and maintained under
laboratory conditions at IBMC Animal Facilities, in
sterile IVC cabinets, with food and water available ad
libitum. All animals used in experiments were aged
from six to eight weeks.
Air pouch model and in vivo cellular recruitment
experiments
Air pouches were raised on the dorsum of isoflurane
(Piramal healthcare, Northumberland, UK) anesthe-
tized BALB/c mice by s.c. injection of 3 ml sterile air
on day 0, and 2 ml on day 3, as previously described
[23,24]. On day 6, the formed synovial air pouch cav-
ities received different stimuli, diluted in endotoxin-
free sterile PBS (Gibco, Gaithersburg, MD, USA) to
a final volume of 1 ml. 1 × 106, 1 × 107 and
1 × 108 L. infantum promastigotes, or the EXO, VDE
and EVs produced by the same number of parasites
were used (final concentration of 106−8/ml).
Furthermore, 1 × 106 L. infantum promastigotes were
injected together with e7 EXO, VDE or EVs. Control
mice received only PBS (negative control) or 20 μg LPS
(positive control). Six hours after intra-pouch inocula-
tion, corresponding to the infiltration peak [25] ani-
mals were euthanized, then the air pouches were
aseptically exposed, and their contents were thoroughly
washed with a total of 3 ml of endotoxin-free, ice-cold
PBS, to collect the recruited cells. The recovered cells
were counted using a Neubauer chamber and the mye-
loid cell populations were resolved by flow cytometry.
Additionally, the activation status of exudate DCs was
also assessed by flow cytometry 24 h after the injection.
Bone marrow-derived macrophages and DCs
generation
Bonemarrow precursors were recovered with RPMI 1640
medium after flushing femurs and tibias of BALB/c mice.
Cells were washed and counted using a Neubauer cham-
ber. Bone marrow-derived DCs (BMDC) were obtained,
based on a protocol previously described [26], by seeding
6 × 106 bone marrow cells in 25 ml of complete RPMI
supplemented with 50 μM 2-mercaptoethanol (Sigma-
Aldrich, St. Louis, MO, USA) and 10% of J558 cell con-
ditioned medium (DC medium). Cells were cultured at
37°C and 5% CO2 for 3 days. After, the same amount of
DC medium was added to each flask. At day 6, half of the
culture supernatant was replaced with the same amount
of fresh DC medium. At day 8, cells were recovered,
counted and finally plated in 96-well culture plates at
a final amount of 1 × 105 cells/well in 200 µl of DC
medium. CD11c+ MHC-II+ cells, considered as BMDC
and determined by flow cytometry, represented more
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than 75% of the culture. Bone marrow-derived macro-
phages (BMMØ) were obtained from non-adhered bone
marrow cells collected after an initial overnight incuba-
tion (37°C and 5%CO2) in complete Dulbecco’s modified
Eagle’s medium (DMEM) (Lonza, Switzerland) as pre-
viously described [27]. Non-adherent cells were recov-
ered, counted and distributed in 96 well culture plates at 1
x 105 cells/well in 100 µl of complete DMEM supplemen-
ted with 5% of L-929 cell conditioned medium (LCCM).
At day 3 of culture, 100 µl of DMEM + 5% LCCM were
added per well. Half of the media was renewed on day 6.
Macrophages were used at day 8 of culture.
In vitro BMMØ and BMDCs stimulation experiments
Fully differentiated BMMØ or BMDCs were cultured
during 48 h with increasing amounts of EXO, VDE or
EVs in a way to assess dose dependency. The extra-
cellular materials used in all experiments were pro-
duced by 6 × 106 (minimum amount to observe an
in vitro effect after 48 h of culture with BMDC),
6 × 107, and 1.2 × 108 parasites – 6e6, 6e7 and 1.2e8,
respectively. For re-stimulation experiments, LPS
(1 µg/ml) or PolyI:C (10 µM) (both from Sigma-
Aldrich, St. Louis, MO, USA) were added after 24 h
of culture and cells were then maintained for an addi-
tional 24 h. As a control, BMDCs were infected with
increasing amounts of L. infantum promastigotes –
DC:L. infantum ratios of 1:0.5, 1:1, 1:2, 1:5, 1:10 and
1:20. After 4 h, cells were extensively washed and the
culture maintained for 48 h. The control cells were left
unstimulated during the 48 culture hours. Cells were
then washed, recovered and stained for analysis of
activation markers expression by flow cytometry.
Labelled monoclonal antibodies and flow
cytometry
The anti-mouse monoclonal antibodies used to per-
form this study were all purchased from BioLegend
(San Diego, CA, USA) unless stated otherwise. FITC α-
MHC-II (I-A/I-E); PE α-Siglec-F (BD Biosciences
(BD), East Rutherford, NJ, USA), PE α-CD40; PerCP-
Cy5.5 α-Ly6C; PE-Cy7 α-CD11b; APC-Cy7 α-CD11c;
APC α-Ly6C; BV510 α-CD86; Pacific BlueTM Ly6G.
Cell viability was assessed (in vitro experiments)
using 7-aminol-actinomycin D (7-AAD, BioLegend).
Surface staining was performed during 30 min in flow
cytometry buffer (PBS + 0.5 % BSA) at 4°C in darkness.
All the antibodies were used at a 1:100 dilution. Cells
were then washed and resuspended in 150 μl flow
cytometry buffer [28]. Flow cytometric acquisitions
were performed in a FACSCantoTM II (BD) and
analysed with FlowJo software v10 (TreeStar,
Ashland, OR, USA). Myeloid cell populations present
in air pouch exudates were resolved as: Eosinophils
(Siglec-F+/SSC-Hint/high), Neutrophils (CD11bhigh/
Ly6Ghigh), Dendritic Cells (CD11c+/MHC-IIint/high)
and Macrophages/monocytes (CD11b+/Ly6C+/Ly6G−/
CD11c−/Siglec-F−) [29]. In some air pouch experi-
ments, the expression of CD40 and MHC-II was stu-
died on DCs. For in vitro experiments, 7AAD+ dead
cells were excluded before analysis of CD40, MHC-II
and CD86 surface expression measured by Mean
Fluorescence Intensity (MFI).
In vitro infection of BMMØ and BMDCs and
cytospin
1 x 106 L. infantum promastigotes with or without 6e6
or 1.2e8 amounts of EXO, VDE or EVs were added to
1 × 105 fully differentiated BMMØ or BMDCs (MOI of
10). Infected non-stimulated cells were used as con-
trols. Cells were gently washed after 4 h of infection
(37°C and 5% CO2) and immediately recovered, or
cultured for 24 or 48 h and recovered afterward.
Recovered cells were subjected to cytospin for 5 min
at 1000 rpm (Shandon CytoSpin II, GMI, Ramsey, MN,
USA), and fixed with 2% paraformaldehyde for 20 min
at RT. Afterwards, the preparations were stained using
the Giemsa method, as previously described [30].
Briefly, slides were immersed for 45 s in Hemacolor
reagent 1, and for 45 more seconds in Hemacolor
reagent 2 (Merk Millipore, Billerica, MA, USA).
Finally, preparations were thoroughly washed with dis-
tilled water, air dried and observed by optical micro-
scopy (100x magnification). The percentage of infected
cells was determined by counting 200 consecutive cells,
both infected and non-infected, in 3 different areas of
the same preparation. The number of parasites within
cells was defined counting 100 different infected cells.
In vivo infections
A low virulence experimental model was used. Distinct
groups of mice were infected intraperitoneally with
1 × 107 L. infantum promastigotes together with increasing
amounts (e7, e8 or e9) of either EXO, VDE or EVs. Control
animals were infected only with 1 × 107 L. infantum pro-
mastigotes. The final infective volumes were adjusted to
100 µl with endotoxin-free sterile PBS. Fifteen days post-
infection, animals were euthanized, and their spleens and
livers were aseptically collected and homogenized using
Falcon®100 µm Cell Strainers (Corning Life Sciences,
Tewksbury, MA, USA) andmanual Potter-Elvehjem tissue
homogenizers, respectively. Spleen and liver parasite
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burdens were then assessed by the limit dilution method
starting with 3 mg and 15 mg of organ, respectively, as
previously described [31].
Statistical analysis
Results are expressed as the mean ± SEM unless otherwise
stated. Some data are presented as relative values to
the relevant control situation. Statistical comparisons
were performed using the unpaired t-test or the one-
sample t-test for comparison of relative values. Analyses
were performed using the GraphPad Prism v6.01 software
(GraphPad Software, San Diego, CA, USA). A p-value
≤0.05 was considered significant. To simplify, only the
detected significant differences are graphically represented
in the different figures (both main and supplementary).
Results
Physical characterization of the extracellular
products
In a previous study, we used a combination of concen-
tration and ultracentrifugation steps to recover VDE
and EVs for proteomic studies, comparing logarithmic
with stationary parasites [9]. Importantly, parasites
were grown in a simple serum-free media, to warrant
that all the recovered materials were of parasite origin
[9,21]. Here we used the same technical approach to
recover extracellular products from stationary para-
sites. The obtained EXO contained mostly morpholo-
gically undefined material with a few scattered EVs
(Figure 1(a)). The VDE was composed predominantly
of undefined products while EVs preparations con-
tained mainly cup-shaped structures. The preparations
protein contents were more similar between VDE and
EXO than between EVs and EXO (S1 Fig). To further
characterize the EVs preparations, size, particle num-
ber and flotation density were determined (Figure 1(b),
S2 Fig). The EVs preparations contained particles with
average sizes between 77 and 130 nm depending on the
method used to measure them (Figure 1(b)). Although
almost 50% of the EVs had a predicted size between 40
and 70 nm (determined by TEM), the global size dis-
tribution ranged from 10 to 200 nm (Figure 1(c)). The
average particle concentration, as determined by NTA,
was 1.84 x 1012/ml. The EVs flotation density and
hydrodynamic average size (determined by DLS)
enabled the recovery of distinct fractions containing
EVs with characteristic sizes and densities (S2 Fig).
Considering the traditional classifications proposed
for EVs, we found particles with density and size simi-
lar to exosomes, exosome-like particles and apoptotic
bodies (S2 Fig) [32]. The process also enabled the
recovery of small-sized RNAs in the EVs preparations
that were protected from RNase treatment (S3 Fig).
Figure 1. EVs and VDE represent distinct aspects of the total EXO. Representative TEM images of equivalent amounts of EXO (I) and
the respective fractions VDE (II) and EVs (III) stained with acetate uracil (a). Average diameter of EVs preparations determined by
TEM, DLS and NTA (b). Polydispersity index (PDI) and average particle number/ml of the preparations are also represented (b).
Average dispersion of particle size (diameter) in the EVs population determined by direct measurement from TEM preparations (c).
All the data are presented as average ± SD from a minimum of 5 independent preparations.
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Extracellular products released by L. infantum
induce a differential and dose-dependent cell
recruitment
Several authors reported early neutrophil recruitment
in air pouch models associated with Leishmania pro-
mastigotes and their EVs [25,33]. To evaluate if EVs-
induced recruitment is specific or a general character-
istic of promastigotes and their EXO we evaluated cell
recruitment in BALB/c air pouches in response to three
doses of EXO, VDE, EVs and L. infantum promasti-
gotes. Six hours after the inoculation, the air pouch
cellular content was characterized by flow cytometry
(Figure 2). A dose-dependent cell recruitment was
induced by live parasites and all the tested stimuli
(Figure 2(a)). When less than 1000 parasites/µl (106
inoculum) were injected no significant recruitment
was observed. The highest dose of EXO, VDE and
EVs significantly increased the cell numbers in the air
pouch (at least p ≤ 0.01), while VDE at the e6 dose
significantly diminished the total cell numbers when
compared with PBS (Figure 2(a); p ≤ 0.05).
Considering specific cellular populations, neutrophils
increased for the higher doses of all tested stimuli
(Figure 2(b); at least p ≤ 0.01). Parasites induced a con-
centration-dependent neutrophil recruitment. On the
contrary, e6 and e7 EVs and e6 VDE significantly
decreased the presence of neutrophils in the air
pouch (p ≤ 0.05). The macrophage/monocyte numbers
were significantly increased, when compared to PBS, at
the highest stimuli concentration tested (at least
p ≤ 0.01). A significant increase in the macrophage/
monocyte recruitment was also observed for the e7 and
e8 parasite doses (at least p ≤ 0.05). After parasites
administration eosinophils remained mostly
unchanged. EXO and VDE at the highest concentration
tested increased the presence of eosinophils in the air
pouch (at least p ≤ 0.05), while VDE at the lowest dose
significantly decreased their recruitment (p ≤ 0.05).
Finally, the abundance of DCs was specific for VDE
and EVs (Figure 2(b), S4A Fig, at least p ≤ 0.05). The
phenotype of recruited DCs by the e8 dose was also
analysed 24 h after inoculation. The expression pat-
terns of surface costimulatory protein CD40 and the
antigen presenting molecule MHC-II were overall simi-
lar to the PBS and distinct from LPS inoculation (S4
Fig), suggesting that these cells are non-activated at the
inoculation site.
As a consequence of the cellular abundances induced
by the stimuli, distinct cellular environments were evi-
dent (Figure 2(c)). At the highest concentration tested
the parasites induce a cellular environment that is indis-
tinguishable from LPS, with neutrophils and eosinophils
constituting more than 95% of the cells present in the air
pouch. The reduction in parasite number led to distinct
cellular environments with a lesser representation of
neutrophils. Although the EXO also induced a cellular
environment dominated by neutrophils, 20% of the cells
present were macrophages/monocytes and DCs. The
VDE presented a cellular environment that was similar
for the three concentrations tested while EVs increased
representation of neutrophils for the e8 concentration
(Figure 2(c)).
L. infantum extracellular material modifies the
cellular recruitment induced by the parasite
Considering that exposition to extracellular products
induced distinct cellular recruitment profiles, their
influence on the intrinsic recruitment induced by the
parasites was investigated. When e7 parasites together
with e7 EXO or its fractions were used (the doses with
an intermediate effect), the individual cellular recruit-
ment observed was always inferior in comparison to
the one induced only by parasites (S5A Fig), although
without statistical significance. Furthermore, with these
experimental conditions, no changes were detected in
the overall profile of the cell populations recruited to
the air pouches (S5B Fig). Interestingly, when reducing
the parasite number to 106, the presence of extracellu-
lar products significantly decreased the recruitment
induced by parasites (Figure 3(a); p ≤ 0.01). In these
conditions, and particularly looking at the effect of the
separated extracellular materials (EVs and VDE) on
the parasite-induced cell recruitment, a tendential
reduction in the proportion of neutrophils (average of
30% to 20%) and a slight increase in the cumulative
frequency of DCs and macrophages was observed
(average of 20% to 30%) (Figure 3(b)), which aligns
with the results described above for the cell recruitment
induced by the extracellular products (Figure 2(b)).
Therefore, the presence of extracellular products in
the infectious inoculum can alter the cellular environ-
ment induced by the parasite alone (Figure 3(a–c)).
L. infantum extracellular products do not activate
DCs and macrophages and hamper their responses
to TLR ligands
To evaluate the direct effect of extracellular products
on DCs and macrophages, cells differentially recruited
by the presence of VDE and EVs, bone marrow-
derived DCs (BMDC) and macrophages (BMMØ)
were cultured in vitro with increasing amounts of
EXO, VDE and EVs. After 48 h, the expression of
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Figure 2. Leishmania infantum extracellular products promote a dose-dependent differential cell recruitment. Relative number of
total cells (a), eosinophils, neutrophils, macrophages/monocytes and dendritic cells (normalized against the PBS recruitment) (b) and
relative cellular abundance (c) in mice pre-formed air pouches 6 h after the injection of PBS (crossed dots), LPS (dark grey dots), 106,
107 and 108 L. infantum promastigotes (black dots) or the EXO (medium grey dots), VDE (light grey dots) and EVs (white dots)
produced by the same number of parasites (e6, e7 and e8). Cells were quantified using a Neubauer chamber and the phenotype
analysed by flow cytometry. Each dot represents an animal. Bars represent the average (± SEM) obtained from the animals studied
in three different experiments. One-sample t-test was used to assess statistical significances comparing to the PBS control group.
Significant differences are highlighted in the figure: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
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CD86, CD40 and MHC-II was studied by flow cyto-
metry as classical indicators of cell activation (Figure 4
(a)). Cell viability, determined as negative staining for
7-AAD, was similar among all the experimental condi-
tions (S6 Fig). BMDCs in the presence of EXO and
VDE presented a dose-dependent decrease of CD40 at
their surface when compared to negative control
(p ≤ 0.05) while CD86 presented a trend to decrease
without clear dose dependency. The EVs did not sig-
nificantly modify the presence of these molecules.
Similar results were observed for CD40 expression on
BMMØ (p ≤ 0.05), while CD86 was not altered in these
cells. The MHC-II expression at the surface of both
BMDC and BMMØ remained similar to the basal levels
for all the conditions tested (Figure 4(a)). Using live
parasites with BMDC in similar experimental settings
a downregulation trend was observed for all the tested
markers (S7 Fig).
The response capacity of antigen presenting cells to
new stimuli is essential for coordination of the subse-
quent immune response. To evaluate this we used the
TLR-4 ligand Lipopolysaccharide (LPS) as secondary
stimuli for BMDC and BMMØ cultured with EXO,
VDE or EVs (Figure 4(b)). Pre-culture with EXO and
EVs decreased the natural upregulation of CD86
induced by LPS (at least p ≤ 0.05). For CD40 the
same was verified, but only for BMDC (at least
p ≤ 0.05). The increase in MHC-II was strongly
impaired in BMMØ for all stimuli tested (at least
p ≤ 0.05) while in BMDCs it was not influenced. The
endosomal TLR-3 ligand polyinosinic:polycytidylic
acid (Poly I:C) was used to confirm the data obtained
with LPS (S8 Fig). With this stimulus, only EXO and
VDE showed ability to suppress the upregulation of the
activation markers (mainly CD86 and CD40).
L. infantum extracellular products favour infection
Since parasite extracellular products can modulate DC
and macrophage activation, their effect on the infection
outcome was addressed in vitro. BMDC and BMMØ
were infected with L. infantum at 1:10 MOI, either
alone or in combination with the lowest or the highest
doses of EXO, VDE or EVs used in the previous
in vitro experiments (Figure 5(a, b)). After 4 h, cells
were extensively washed, the infection quantified and
followed up at 24 and 48 h. Neither EXO nor its
components affected the initial infection at 4 h
(Figure 5(a)). However, at 48 h the presence of EXO
and its fractions tendentiously increased infection in
BMDCs and apparently impaired parasite elimination
by BMMØ (Figure 5(a)).
Figure 3. Leishmania infantum extracellular products alter the
cell recruitment profile induced by the parasite. Relative num-
ber of total cells (a), frequencies of eosinophils, neutrophils,
macrophages and dendritic cells (b) and relative cellular abun-
dance (c) in mice pre-formed air pouches, 6 h after the injec-
tion of 106 L. infantum promastigotes (black), alone or together
with EXO (dark grey), VDE (light grey) and EVs (white) produced
by 107 parasites (e7). Each dot represents an animal; bars (a)
and horizontal lines (b) indicate group means (± SEM) of each
experimental group. One-sample t-test was used to assess
statistical significances compared to parasites only. Significant
differences are highlighted in the figure: ** p ≤ 0.01.
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Finally, we addressed if the presence of exogenous
products in the initial inoculum could translate into
a real advantage in L. infantum infectivity in vivo. To
assess this, we used a low virulence experimental setup.
We infected BALB/c mice i.p. with 107 L. infantum that
result in 50% of productive infections with readout
only in spleen. Challenges were performed alone or in
combination with different doses of EXO and its
Figure 4. In vitro dose-dependent immunomodulatory effect of L. infantum extracellular material on BMDC and BMMØ. Normalized
expression levels of CD86, CD40 and MHC-II in BMDC and BMMØ cultured for 48 h in the presence of increasing amounts of EXO
(dark grey boxes), VDE (light grey boxes) and EVs (white boxes), without (a) or with (b) LPS re-stimulation 24 h after the addition of
the primary stimuli. In re-stimulation assays, black boxes represent the results obtained for the positive control (LPS stimulation
during the last 24 h of culture). Results are relative to the values obtained for non-stimulated cells (dotted line) and boxes illustrate
the average, minimum and maximum values of three different experiments. One-sample t-test was used to assess statistical
significances to the hypothetical negative (a) and positive (b) values. Significant differences are highlighted in the figure: * p ≤ 0.05;
** p ≤ 0.01.
JOURNAL OF EXTRACELLULAR VESICLES 9
fractions (Figure 5(b)) and parasite burdens were
determined 2 weeks after. Liver parasite burdens were
below the detection limit in all the experimental set-
tings. Notably, the parasite burden in the spleen
increased in a concentration-dependent manner when
L. infantum was co-inoculated with the extracellular
products. This increase was significant for the e9 dose
of all the fractions (Figure 5(b); p ≤ 0.05 or 0.001
for VDE).
Discussion
Several studies suggest that Leishmania derived EVs
might have a role in the infectious process [8,13].
Still, no study evaluated the relevance of EVs in the
context of other extracellular products. To understand
the effects of the secretome individual fractions is rele-
vant when we consider the study of new virulence
factors, but when the objective is to study the infectious
process and translate to the natural infection, we must
consider the secretome as a whole. More so relevant is
this when TEM data suggests that EVs are not the most
abundant component of the EXO recovered from the
parasite cultures (Figure 1(a)). In fact, VDE presents
higher protein levels as we shown in a previous study
[9] and is suggested by the SDS-PAGE profile (S1 Fig).
Therefore, it is essential to evaluate if properties
reported for Leishmania EVs are maintained in the
presence of VDE.
For the biological assays, the concept of extracellular
products produced by cell number/time was used. This
is an accepted approach to study EVs. Indeed, in one of
Figure 5. Leishmania infantum extracellular material favours infection. (a) BMDC and BMMØ were infected during 4 h with
L. infantum promastigotes in the presence or not of Leishmania extracellular products. Parasites were then washed away and
cells recovered or left in culture. Four, twenty-four or forty-eight hour after infection cells were cytospined, stained by the Giemsa
method and the infection analysed under the microscope. The percentage of infected cells at the different time-points is indicated.
Symbols and bars represent the mean ± SEM of three independent experiments. (b) Splenic parasite burdens of mice infected
intraperitoneally with 107 L. infantum promastigotes together with EXO (dark grey dots), VDE (light grey dots) or EVs (white dots)
produced by107 (e7), 108 (e8) or 109 (e9) parasites. Every symbol represents a mouse. Lines represent the mean of each experimental
group. Statistical significance was attained comparing each group with the control group (mice infected only with 107 L. infantum
promastigotes, dashed line, n = 6), using the One-sample t-test. Significant differences are highlighted in the figure: * p ≤ 0.05, ***
p ≤ 0.001.
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the few exosome clinical applications reported, the
therapeutic unit is described as “the EV fraction pre-
pared from supernatants of 4 × 107 mesenchymal stem
cells that had been conditioned for 48 h” [34]. We
considered this approach as the most relevant in our
context, in opposition to the regularly used normal-
ization by protein quantification [8]. Bearing in mind
that surface interactions are essential for cross-talk
between pathogens and immune system, even the
equivalence between 1000 vesicles of 20 nm or 1 vesicle
of 200 nm is disputable. In fact, considering protein
amount proportional to the intra-vesicular volume,
an EV with 200 nm diameter would have the same
protein amount as 1000 vesicles of 20 nm. Notably,
the measured EVs diameter variation in our samples
was 10x (Figure 1(c) translating into a volume variation
of 1000x. Still, extrapolation to other biological settings
due to the heterogeneous nature of EVs is always
complex.
The recovered EVs are in accordance with those
reported previously (Figure 1(b)) [12,33]. Moreover,
distinct EVs populations with characteristic size and
density were isolated suggesting a complex mixture of
EVs (S2 Fig). Even so, this is still an incomplete char-
acterization and a limitation of the study, as the need
for parasite removal from the EXO by filtration elim-
inates particles like apoptotic bodies and large micro-
vesicles. The recovered EVs also contained low
molecular weight RNA as was already reported for
other species of Leishmania (S3 Fig) [35]. These char-
acteristics are in accordance with the available data on
Leishmania EVs.
Several authors suggest that Leishmania derived EVs
possibly function as extensions of the parasites poten-
tiating their intrinsic capacities and contributing to
immune response deactivation [13]. Here, cell recruit-
ment associated with parasites in the air pouch model
was reproduced by high doses of EXO while EVs or
VDE presented dose-dependent characteristic pheno-
types (Figure 2) [25]. Importantly, the selected concen-
trations of parasites and stimuli were used having in
mind the theoretical concentration expected to be
found in the site of inoculation: 500–600 parasites
[36–38] deposited in the blood pool originated by the
vector feeding process, which has a volume of
0.05–0.42 mm3 [39], giving a final average concentra-
tion of 107 parasites/ml. At high EXO quantities,
pathogen-associated molecular patterns (PAMPs) are
expected to activate endothelial cells and resident
macrophages leading to neutrophils recruitment
[40,41]. The few TLR activators described for
Leishmania are expected to be part of the extracellular
products. Lipophosphoglycan (LPG) is a TLR2 agonist
capable of activating mouse macrophages and human
NK cells, in a MyD88-dependent manner [42–44].
Also, glycosylphosphatidylinositol, that in T. cruzi acti-
vates TLR2 and TLR4 [45–47], might be a PAMP pre-
sent among Leishmania extracellular products. Even
proteins might have unexpected capacities to interact
with TLRs, as L. infantum Sir2 was demonstrated to
induce the maturation of DCs in a TLR2-dependent
manner with the secretion of IL-12 and TNF-α [48].
Neutrophil and eosinophil recruitment has also been
associated with parasite-derived chemotactic compo-
nents like the Granulocyte Chemotactic Factor
described in conditioned media of several Leishmania
species [49].
Remarkably, the lower doses of VDE tested induced
less cell recruitment to the air pouch when compared to
the PBS control, which was due to a lesser number of
neutrophils and eosinophils (Figure 2(b)). This modula-
tion was confirmed in the context of parasite-induced
cellular recruitment in the presence of inhibitory concen-
trations of extracellular products (Figure 3, S5 Fig). Lipid
mediators like lipoxin A4 are known to be associated with
the resolution of inflammation, inhibiting neutrophil
chemotaxis and promoting non-inflammatory macro-
phage recruitment [41,50]. Pathogens like Pseudomonas
aeruginosa and Toxoplasma gondii can induce local
lipoxin production [51,52]. Intriguingly, Leishmania was
shown to release a molecule described to interact with the
lipoxin A4 receptor leading to increased survival of
the parasites inside macrophages [53]. The negative
immune regulation observed can also be justified by an
adaptation of the “trojan horse” theory [49,54]. Exosomes
and apoptotic bodies found in the EVs preparations are
known to contain phosphatidylserine exposed at their
surface [55,56], a known “eat me signal”, with the poten-
tial to modulate cell recruitment and promote the gen-
eration of an anti-inflammatory environment [57–59],
beneficial for parasite persistence.
Dendritic cells were the only cell type that presented
a fraction specific recruitment in response to VDE and
EVs (Figure 2). This phenotype was not observed for
EXO, suggesting that the recruitment might be masked
by its inflammatory profile in the higher doses tested.
Significantly, the recruitment of DCs was retained when
EVs or VDE were co-inoculated with parasites, suggest-
ing that both the nature and the dose of the extracellular
products might modulate the parasite associated cellular
recruitment. Moreover, DCs present upon Leishmania
and extracellular products inoculation in the air pouch
were not activated (S4 Fig). The downregulation of
activations markers by parasites was described by sev-
eral authors and is thought to be an essential component
of the Leishmania immunomodulatory arsenal [5,26].
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Ultimately the DCs recruitment to the infection site and
their subsequent deactivation might lead to an adaptive
immune response delay, giving the parasite enough
time to either escape the inoculation site inside
a permissive phagocytic cell or create a privileged
niche that enables a silent progression of infection
[60,61].
Intracellularly these parasites can dampen the
immune response by direct modulation of host signal-
ling [10,11]. Here we show that EXO and its compo-
nents, in the dose range tested, presented distinct
capacities to alter the expression of CD40, CD86 and
MHCII in vitro, being VDE the most capable fraction
(Figure 4(a)). This specific effect was expected as VDE
is highly enriched in several known immunomodula-
tory proteins. GP63, a metalloprotease that may cleave
cytosolic host proteins like tyrosine phosphatases [62]
and serine/threonine kinase (mTOR) [11], contribut-
ing to macrophage anergy [62,63], was shown by our
group to be particularly abundant in the exoproteome
[9]. Furthermore, elongation factor-1α, another major
component of Leishmania exoproteome, was shown to
deactivate macrophage functions by triggering the Src
homology 2 domain in tyrosine phosphatase-1 [17].
Also, LPG was shown to attenuate multiple macro-
phage functions including phagosome maturation,
oxygen radical formation and cell signalling through
effects on protein kinase C [64–66]. The cellular
alterations induced by extracellular products were
not limited to the downregulation of activation mar-
kers. Interestingly, although EVs did not alter the
basal phenotype of DCs and macrophages, they pre-
sented an equivalent potency to VDE in dampening
the response to the TLR4 agonist LPS (Figure 4(b)). It
is important to note that this effect was not evident
when re-stimulation was performed with the TLR3
agonist Poly I:C (Figure S8). The cellular localization
of the TLR (surface for TLR4 or endosomes for TLR3)
might be important for these distinct phenotypes as
free molecules present in EXO, or VDE might more
easily access intracellular compartments. The impor-
tance of cellular alterations induced by exogenous
products goes beyond the obvious effect on infected
cells, as their presence in the initial inoculum might
also contribute to non-infected cells deactivation, pre-
venting the formation of a zonal NO gradient,
described to be important for parasite clearance [67].
Using in vitro infection models no differences in para-
site uptake were observed, suggesting that the presence of
exogenous products in the initial inoculum neither stimu-
lates nor hinders parasite phagocytosis (Figure 5(a, b)).
Still, there was a modest increase of infection at the latter
time points suggesting that the exogenous products might
potentiate infectivity. The absence of significance might be
justified by the intrinsic capacity of the parasite to induce
modulation of infected cell’s responses (Fig S7). In fact, in
our in vivo infection model, the presence of exogenous
products in the inoculum potentiated the infection in
a dose-dependent manner (Figure 5(c)), suggesting that
parasite-secreted components can play a role in infection
establishment. Interestingly, when 108 parasites were used
in the same context no advantage was observed, suggest-
ing that in this case parasite numbers might have been so
overwhelming that no further biological benefit was
granted by EXO or its components (data not shown).
As far as we are concerned, we report for the first time
that the outcome of the interactions between parasite
exogenous products and the immune system is not only
influenced by their nature but also by their quantity,
suggesting that the event of a productive infection
would have to include a specific combination of parasite,
parasite-derived material and also sand fly saliva-derived
components (saliva and microbiome). Interestingly, the
described exoproteome dual capacity of apparent inflam-
mation induction or dampening might be essential for
distinct aspects of the parasite life cycle, such as the need
to recruit susceptible cells and/or to prevent their activa-
tion. In the moment of transmission, the relevance of EVs
immunomodulatory potential has always to be consid-
ered in the context of the whole Leishmania secretome.
However, the importance of EVs alone might be more
relevant for the intracellular stage of the parasite (which
resides and replicates within the acidic host-cell phagoly-
sosome) as these will probably be key for the delivery of
parasite-derived components to the cell cytoplasm that
could contribute to the manipulation of the host cell,
subject we are now focusing on.
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